|
|
|
| home > white papers > Financial implications of off-site visits in clinical research, perception versus reality - Illingworth Research |
|
|
 WHITE PAPERS |
|
Illingworth Research
|
|
Financial implications of off-site visits in clinical research, perception versus reality
|
|
The concept of patient centricity is still relatively new within
clinical trials. For too long, the most important person in the trial
has been overlooked… the patient. Here, we explore the benefits of
conducting a more patient-centric trial for the patient, site and
sponsor through mobile, or ‘off -site’ visits. These advantages are much
greater than purely financial, although the financial implications of
running a more patient-focused clinical trial may previously have
deterred some from this approach. Home nursing in clinical trials
continues to be thought of as a high value “premium” service, which many
sponsors decline in an attempt to remain within budget for the trial.
However, is the actual cost of off -site nursing more expensive than the
traditional site model?
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Northway Biotechpharma and Memo Therapeutics AG collaborate on the fast-track manufacturing of a SARS-CoV-2- neutralizing antibody for the therapy of COVID-19
Vilnius, Lithuania, and Schlieren, Switzerland – August 11, 2020 – Northway Biotechpharma (Northway), a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Swiss biotech company Memo Therapeutics AG (MTx), announce a new partnership to manufacture MTx’s therapeutic COVID-19 antibody candidate in a 4-month fast-track process approved by regulatory authorities.
More info >> |
|
 |
White Papers |
 |
|
Maximize the ROI of Your Post-Approval Research
Bioclinica
Expenditures in post-approval (Phase IV) research are going up across the pharmaceutical, biotech and medical device industries. Given the resources you’ve committed to post-approval research, you may be wondering if you’re getting the greatest possible return on your investment.
Discover how to harness the power of post-approval research to increase data collection, reduce resource burn, save money, and maximize your ROI!
More info >> |
|
 |
Industry Events |
 |
BIO-Europe Digital
26-29 October 2020, Digitally delivered
Global connections are more important than ever. With the same powerful one-to-one partnering and valuable content, BIO-Europe Digital continues to help you drive your life science partnering forward.
More info >> |
|
|
|
.jpg)
